Identification of an annexin-like protein and its possible role in the Aplysia eye circadian system.
Light and serotonin regulate the phase of the circadian rhythm of the isolated eye of Aplysia. To screen for possible protein components of the eye circadian oscillator, we identified a number of proteins whose synthesis was altered in opposite ways by light and serotonin. The cellular function of one of these proteins was investigated by obtaining a partial amino acid sequence of it and by examining its immunoreactivity. A 38-amino acid sequence was obtained from a 40-kDa (isoelectric point 5.6) protein. A greater than 60% amino acid identity existed between this sequence and sequences of a family of calcium/phospholipid-binding proteins called annexins. Furthermore, the 40-kDa protein reacted with antibodies generated against a conserved amino acid sequence of annexins and with antibodies raised against human annexin I. The identification of the 40-kDa, light- and serotonin-regulated protein as an annexin led us to hypothesize that arachidonic acid metabolism plays a role in the Aplysia eye circadian system. To test this hypothesis, we examined the ability of an inhibitor of the arachidonic acid metabolic pathway to perturb the eye rhythm. Pulse treatments of isolated eyes with a lipoxygenase inhibitor, nordihydroguaiaretic acid, phase shifted the rhythm. The phase-shifting ability of nordihydroguaiaretic acid suggests that arachidonic acid and some of its metabolites may play a role in the eye circadian system. The results of our studies raise the possibility that links may exist between the 40-kDa annexin-like protein, arachidonic acid metabolism, and the circadian oscillator.
Department of Biochemical and Biophysical Sciences, University of Houston, TX 77204-5934.
U
U
Raju
M
M
Nunez-Regueiro
R
R
Cook
M A
MA
Kaetzel
S C
SC
Yeung
A
A
Eskin
D000098:Acetophenones / Q000494:pharmacology; D000595:Amino Acid Sequence; D000818:Animals; D017302:Annexins / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D001048:Aplysia; D016718:Arachidonic Acid / Q000037:antagonists & inhibitors; D002940:Circadian Rhythm / Q000502:physiology*; D005123:Eye / Q000378:metabolism; D005136:Eye Proteins / Q000378:metabolism / Q000502:physiology*; D015151:Immunoblotting; D066298:In Vitro Techniques; D009637:Masoprocol / Q000494:pharmacology; D008969:Molecular Sequence Data; D008970:Molecular Weight; D009799:Ocular Physiological Phenomena; D010449:Peptide Mapping; D010740:Phospholipases / Q000037:antagonists & inhibitors
D000098:Acetophenones; D017302:Annexins; D005136:Eye Proteins; D016718:Arachidonic Acid; D009637:Masoprocol; D010740:Phospholipases; C006821:4-bromophenacyl bromide